InvestorsHub Logo
Followers 5
Posts 528
Boards Moderated 0
Alias Born 07/16/2013

Re: James salmon post# 37330

Friday, 10/06/2017 9:38:34 AM

Friday, October 06, 2017 9:38:34 AM

Post# of 108191
Thanks James. Seems to be talking mostly about the very expensive CAR-T treatments. Glad that our vaccine is low cost and thus far has had a great safety profile. If Efficacy ends up being equal; one would speculate that low cost and safety will win out in the end.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News